Neuropeptide Y impairs the acquisition of conditioned defeat in Syrian hamsters

Neurosci Lett. 2019 Jan 18:690:214-218. doi: 10.1016/j.neulet.2018.09.049. Epub 2018 Oct 9.

Abstract

Recent evidence indicates that Neuropeptide Y (NPY) may function as a potent anxiolytic as well as a resilience factor that can insulate the brain from the effects of stress. However, most of these studies have utilized physical stressors such as shock or restraint. In the present study, we use an ethologically-based model in Syrian hamsters (Mesocricetus auratus) called Conditioned Defeat (CD) to investigate whether NPY can ameliorate the effect of social defeat stress. In the CD model, a male Syrian hamster is socially defeated by a larger, more aggressive conspecific. Subsequently, when paired with a smaller, non-aggressive intruder (NAI) in its own home cage, changes in its behavioral repertoire occur, including a reduction in aggression and chemosensory (social) investigation, and a concomitant increase in submissive behaviors. In Experiment 1, hamsters were infused intracerebroventricularly (icv) with NPY prior to social defeat, and 24-hours later, hamsters were exposed to a NAI. Results indicate that NPY significantly reduced submissive/defensive behaviors in socially defeated hamsters compared to control animals. In Experiment 2, we examined whether this effect was mediated by the NPY Y1 receptor. Subjects were first pre-treated with the Y1 receptor antagonist BIBP 3226 or vehicle, followed by NPY and then socially defeated. Upon testing with a NAI 24-hours later, pretreatment with BIBP 3226 failed to block the NPY effect compared to controls. These results demonstrate that NPY may function as an important resilience factor in socially defeated hamsters, but that these effects are not mediated by the Y1 receptor.

Keywords: Anxiety; Defensive behaviors; Social defeat; Stress; Voluntary exercise.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arginine / analogs & derivatives
  • Arginine / pharmacology
  • Behavior, Animal / drug effects
  • Conditioning, Psychological / drug effects*
  • Cricetinae
  • Dominance-Subordination*
  • Infusions, Intraventricular
  • Male
  • Neuropeptide Y / administration & dosage
  • Neuropeptide Y / antagonists & inhibitors
  • Neuropeptide Y / pharmacology*

Substances

  • BIBP 3226
  • Neuropeptide Y
  • Arginine